SM
ONCS

Salzhauer Michael’s OncoSec Medical Incorporated ONCS Stock Holding History

Salzhauer Michael’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-20,799
Closed -$53.7K – 108
2023
Q1 		$53.7K Hold
20,799
– – 0.05% 92
2022
Q4 		$34.9K Buy
20,799
+7,332
+54% +$41.1K 0.02% 104
2022
Q3 		$145K Hold
13,467
– – 0.09% 95
2022
Q2 		$220K Hold
13,467
– – 0.13% 87
2022
Q1 		$341K Sell
13,467
-1,140
-8% -$24K 0.15% 79
2021
Q4 		$308K Buy
14,607
+2,002
+16% +$67.7K 0.12% 81
2021
Q3 		$591K Buy
12,605
+10,455
+486% +$530K 0.24% 59
2021
Q2 		$133K Buy
2,150
+454
+27% +$41.2K 0.06% 107
2021
Q1 		$178K Buy
1,696
+455
+37% +$62.3K 0.09% 100
2020
Q4 		$176K Sell
1,241
-227
-15% -$24.2K 0.13% 86
2020
Q3 		$109K Hold
1,468
– – 0.12% 82
2020
Q2 		$66K Hold
1,468
– – 0.09% 78
2020
Q1 		$41K Hold
1,468
– – 0.07% 95
2019
Q4 		$58K Buy
1,468
+823
+128% +$37.2K 0.03% 128
2019
Q3 		$28K Buy
+645
New +$30.3K 0.01% 129

Salzhauer Michael's ONCS Position: Q2 2023 in Review

Salzhauer Michael sold out of OncoSec Medical Incorporated (ONCS) in Q2 2023, closing a stake of 20,799 shares — an estimated $53.7K sold.

Salzhauer Michael first reported a position in ONCS in Q3 2019 and held it in 15 quarters. The position peaked at $591K in Q3 2021. 0 funds tracked by Wall St. Rank hold ONCS as of Q2 2023.

  • Salzhauer Michael reported no remaining OncoSec Medical Incorporated position as of Q2 2023 after selling out during the quarter.
  • Salzhauer Michael sold 20,799 OncoSec Medical Incorporated shares in Q2 2023, an estimated $53.7K.
  • Salzhauer Michael first reported a position in OncoSec Medical Incorporated in Q3 2019 and held it in 15 quarters.
  • Salzhauer Michael's OncoSec Medical Incorporated position peaked at $591K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2023.

Based on Salzhauer Michael's 13F filing for Q2 2023, filed 8 Aug 2023.